Diabetic retinopathy: Early diagnosis and effective treatment.
Kollias AN, Ulbig MW.
Dtsch Arztebl Int. 2010 Feb;107(5):75-83; quiz 84. doi: 10.3238/arztebl.2010.0075. Epub 2010 Feb 5.
Diabetic retinopathy.
Kohner EM, Oakley NW.
Metabolism. 1975 Sep;24(9):1085-102. doi: 10.1016/0026-0495(75)90102-x.
Diabetic retinopathy. Background, classification, pathophysiology.
Mames RN.
J Fla Med Assoc. 1994 Apr;81(4):240-2.
Diabetic retinopathy.
Smith SC.
Nurse Pract Forum. 1998 Mar;9(1):13-8.
Potential Biomarkers in Diabetic Retinopathy.
Adki KM, Kulkarni YA.
Curr Diabetes Rev. 2020;16(9):971-983. doi: 10.2174/1573399816666200217092022.
Secretogranin III: a diabetic retinopathy-selective angiogenic factor.
Li W, Webster KA, LeBlanc ME, Tian H.
Cell Mol Life Sci. 2018 Feb;75(4):635-647. doi: 10.1007/s00018-017-2635-5. Epub 2017 Aug 30.
Diabetic Retinopathy: Recent Updates on Different Biomarkers and Some Therapeutic Agents.
Khan AA, Rahmani AH, Aldebasi YH.
Curr Diabetes Rev. 2018;14(6):523-533. doi: 10.2174/1573399813666170915133253.
[Diabetic retinopathy: pathogenesis and therapeutic implications].
Pelikánová T.
Vnitr Lek. 2016 Fall;62(7-8):620-8.
Is There any Correlation Between Diabetic Retinopathy and Risk of Cardiovascular Disease?
Shoeibi N, Bonakdaran S.
Curr Diabetes Rev. 2017;13(1):81-86. doi: 10.2174/1573399812666151012115355.
Diabetic retinopathy screening using deep neural network.
Ramachandran N, Hong SC, Sime MJ, Wilson GA.
Clin Exp Ophthalmol. 2018 May;46(4):412-416. doi: 10.1111/ceo.13056. Epub 2017 Oct 4.
